X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4085) 4085
Publication (311) 311
Book Review (35) 35
Book Chapter (16) 16
Conference Proceeding (6) 6
Dissertation (4) 4
Paper (3) 3
Web Resource (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2785) 2785
index medicus (2761) 2761
male (1639) 1639
diabetes mellitus, type 2 - drug therapy (1537) 1537
animals (1418) 1418
dipeptidyl-peptidase iv inhibitors - therapeutic use (1299) 1299
female (1227) 1227
type 2 diabetes (1140) 1140
endocrinology & metabolism (1081) 1081
middle aged (945) 945
diabetes (934) 934
hypoglycemic agents - therapeutic use (928) 928
dipeptidyl peptidase 4 - metabolism (816) 816
glucagon-like peptide-1 (767) 767
aged (724) 724
dipeptidyl-peptidase iv inhibitors - pharmacology (705) 705
pharmacology & pharmacy (704) 704
sitagliptin (613) 613
adult (584) 584
glucose (582) 582
analysis (579) 579
rats (560) 560
dipeptidyl-peptidase iv inhibitors - adverse effects (557) 557
mice (553) 553
treatment outcome (531) 531
diabetes mellitus, type 2 - blood (529) 529
adamantane - analogs & derivatives (484) 484
hypoglycemic agents (468) 468
biochemistry & molecular biology (465) 465
insulin (461) 461
metformin (439) 439
double-blind (432) 432
dipeptidyl-peptidase iv inhibitors - administration & dosage (423) 423
diabetes mellitus (420) 420
dipeptidyl peptidase-4 inhibitor (417) 417
hypoglycemic agents - adverse effects (414) 414
blood glucose - metabolism (408) 408
glycemic control (406) 406
care and treatment (404) 404
research (386) 386
drug therapy, combination (380) 380
vildagliptin (372) 372
dipeptidyl-peptidase-iv (361) 361
dipeptidyl peptidase-iv (360) 360
blood glucose - drug effects (354) 354
peptidase (354) 354
peptides (342) 342
sitagliptin phosphate (341) 341
risk factors (336) 336
dipeptidyl peptidase iv (328) 328
hypoglycemic agents - administration & dosage (328) 328
dextrose (309) 309
hypoglycemic agents - pharmacology (309) 309
internal medicine (306) 306
drug therapy (303) 303
expression (303) 303
safety (302) 302
type-2 diabetes-mellitus (300) 300
diabetes therapy (296) 296
type 2 diabetes mellitus (295) 295
metformin - therapeutic use (291) 291
dipeptidyl peptidase-4 inhibitors (282) 282
enzymes (279) 279
glucagon (279) 279
dpp-4 inhibitor (278) 278
glp-1 (278) 278
cd26 (276) 276
glycated hemoglobin a - metabolism (276) 276
efficacy (272) 272
adamantane - therapeutic use (270) 270
health aspects (264) 264
diabetes mellitus, type 2 - complications (263) 263
double-blind method (263) 263
beta-cell function (256) 256
proteins (250) 250
inhibitors (246) 246
medicine & public health (232) 232
medicine, general & internal (232) 232
physiological aspects (230) 230
mellitus (229) 229
diabetes mellitus, type 2 - metabolism (223) 223
dose-response relationship, drug (223) 223
proteases (221) 221
hyperglycemia (219) 219
clinical trials (216) 216
medicine, research & experimental (216) 216
mice, inbred c57bl (216) 216
inflammation (215) 215
time factors (214) 214
dipeptidyl peptidase 4 (212) 212
cell biology (208) 208
linagliptin (208) 208
therapy (207) 207
dipeptidyl peptidase 4 - blood (206) 206
insulin resistance (205) 205
dipeptidyl-peptidase iv inhibitors (199) 199
abridged index medicus (198) 198
improves glycemic control (198) 198
hypoglycemia (195) 195
triazoles - therapeutic use (195) 195
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4052) 4052
German (13) 13
Japanese (8) 8
French (7) 7
Korean (7) 7
Chinese (6) 6
Spanish (5) 5
Dutch (1) 1
Hungarian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Agricultural and Food Chemistry, ISSN 0021-8561, 07/2014, Volume 62, Issue 26, pp. 6147 - 6158
Greek oregano (Origanum vulgare), marjoram (Origanum majorana), rosemary (Rosmarinus officinalis), and Mexican oregano (Lippia graveolens) are concentrated... 
DPP-IV | PTP1B | rosemary | marjoram | oregano | hispidulin | type 2 diabetes mellitus | PHENOLIC-COMPOUNDS | MEDICINAL HERBS | FOOD SCIENCE & TECHNOLOGY | IDENTIFICATION | ANTIOXIDANT PROPERTIES | LIPPIA | LAMIACEAE | TYROSINE-PHOSPHATASE 1B | MASS SPECTROMETRIC ANALYSIS | AGRICULTURE, MULTIDISCIPLINARY | ROSEMARY ROSMARINUS-OFFICINALIS | CHEMISTRY, APPLIED | EXTRACTS | Plant Extracts - chemistry | Crops, Agricultural - economics | Lippia - chemistry | Plant Extracts - pharmacology | Humans | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Protein Kinase Inhibitors - chemistry | Protein Kinase Inhibitors - analysis | Dipeptidyl-Peptidase IV Inhibitors - analysis | Crops, Agricultural - chemistry | Molecular Structure | Protein Tyrosine Phosphatase, Non-Receptor Type 1 - genetics | Plant Leaves - chemistry | Recombinant Proteins - metabolism | Dipeptidyl-Peptidase IV Inhibitors - isolation & purification | Diabetes Mellitus, Type 2 - enzymology | Protein Tyrosine Phosphatase, Non-Receptor Type 1 - antagonists & inhibitors | Recombinant Proteins - chemistry | Dipeptidyl-Peptidase IV Inhibitors - chemistry | Plant Extracts - isolation & purification | Recombinant Proteins - genetics | Protein Kinase Inhibitors - isolation & purification | Drug Discovery | Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism | Animals | Ligands | Molecular Docking Simulation | Origanum - chemistry | Protein Kinase Inhibitors - pharmacology | Diabetes Mellitus, Type 2 - drug therapy | Sus scrofa | Rosmarinus - chemistry
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 4/2011, Volume 50, Issue 4, pp. 253 - 265
Patients with type 2 diabetes mellitus often have impaired renal function or may have impaired hepatic function, which can pose significant safety and... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Research-and-development | Antihyperglycaemics, pharmacokinetics | Type-2-diabetes-mellitus | Diabetes-mellitus | Dipeptides, pharmacokinetics | Renal-impairment | Saxagliptin, pharmacokinetics | Haemodialysis | Liver-dysfunction | METFORMIN | THERAPY | CHRONIC LIVER-DISEASE | SAFETY | IMPROVES GLYCEMIC CONTROL | RISK | PHARMACOLOGY & PHARMACY | RANDOMIZED CONTROLLED-TRIAL | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Hepatic Insufficiency - urine | Dipeptides - pharmacokinetics | Humans | Middle Aged | Hypoglycemic Agents - analysis | Half-Life | Dipeptides - urine | Male | Metabolic Clearance Rate | Adamantane - urine | Adamantane - analysis | Adamantane - blood | Adult | Dipeptidyl-Peptidase IV Inhibitors - analysis | Female | Renal Insufficiency - blood | Hepatic Insufficiency - metabolism | Adamantane - pharmacokinetics | Adamantane - adverse effects | Adamantane - analogs & derivatives | Severity of Illness Index | Hypoglycemic Agents - pharmacokinetics | Dialysis Solutions - chemistry | Dipeptides - adverse effects | Dipeptides - analysis | Renal Insufficiency - metabolism | Renal Insufficiency - urine | Hepatic Insufficiency - blood | Kidney Failure, Chronic - metabolism | Kidney Failure, Chronic - therapy | Dipeptidyl-Peptidase IV Inhibitors - pharmacokinetics | Kidney Failure, Chronic - blood | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Dipeptides - blood | Renal Dialysis | Complications and side effects | Liver diseases | Physiological aspects | Dosage and administration | Research | Pharmacokinetics | Saxagliptin
Journal Article
Journal Article
Journal Article
Journal of Chromatographic Science, ISSN 0021-9665, 01/2016, Volume 54, Issue 1, pp. 79 - 87
A single, simple, selective and validated high performance thin layer chromatographic (HPTLC) method was developed for the determination of either linagliptin... 
VALIDATION | CHEMISTRY, ANALYTICAL | BIOCHEMICAL RESEARCH METHODS | Metformin - analysis | Dipeptidyl-Peptidase IV Inhibitors - analysis | Limit of Detection | Reproducibility of Results | Complex Mixtures | Chromatography, Thin Layer - methods
Journal Article